Ülke: ABD
Dil: İngilizce
Kaynak: NLM (National Library of Medicine)
OMEGA-3-ACID ETHYL ESTERS (UNII: D87YGH4Z0Q) (OMEGA-3 FATTY ACIDS - UNII:71M78END5S)
Atlantic Biologicals Corps
OMEGA-3-ACID ETHYL ESTERS
OMEGA-3-ACID ETHYL ESTERS 1 g
ORAL
PRESCRIPTION DRUG
Omega-3-acid ethyl esters capsules, USP are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia (HTG). Patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules, USP and should continue this diet during treatment with omega-3-acid ethyl esters capsules, USP. Usage Considerations: Laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters capsules, USP. Every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. Medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consider
NDC:17856-0034-2 in a POUCH of 50 CAPSULE, LIQUID FILLEDS
Abbreviated New Drug Application
OMEGA-3-ACID ETHYL ESTERS- OMEGA-3-ACID ETHYL ESTERS CAPSULE, LIQUID FILLED ATLANTIC BIOLOGICALS CORPS ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE OMEGA-3-ACID ETHYL ESTERS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR OMEGA-3-ACID ETHYL ESTERS. OMEGA-3-ACID ETHYL ESTERS CAPSULES USP, FOR ORAL USE INITIAL U.S. APPROVAL: 2004 RECENT MAJOR CHANGES Indications and Usage, Limitations of Use 06/2013 (1) INDICATIONS AND USAGE Omega-3-acid ethyl esters capsules, USP are a combination of ethyl esters of omega 3 fatty acids, principally EPA and DHA, indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia (HTG). (1) Limitations of Use: The effect of omega-3-acid ethyl esters capsules, USP on the risk for pancreatitis has not been determined. (1) The effect of omega-3-acid ethyl esters capsules, USP on cardiovascular mortality and morbidity has not been determined. (1) DOSAGE AND ADMINISTRATION The daily dose of omega-3-acid ethyl esters capsules, USP is 4 grams per day taken as a single 4-gram dose (4 capsules) or as two 2-gram doses (2 capsules given twice daily). (2) Patients should be advised to swallow omega-3-acid ethyl esters capsules, USP whole. Do not break open, crush, dissolve, or chew omega-3-acid ethyl esters capsules, USP. (2) DOSAGE FORMS AND STRENGTHS 1 gram transparent soft-gelatin capsules. (3) CONTRAINDICATIONS Omega-3-acid ethyl esters capsules, USP are contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to omega-3-acid ethyl esters, USP or any of its components. (4) WARNINGS AND PRECAUTIONS In patients with hepatic impairment, monitor ALT and AST levels periodically during therapy. (5.1) Omega-3-acid ethyl esters may increase levels of LDL. Monitor LDL levels periodically during therapy. (5.1) Use with caution in patients with known hypersensitivity to fish and/or shellfish. (5.2) There is a possible associati Belgenin tamamını okuyun